Lantern’s Core Operational Strengths
Through professional relationships with a growing range of partners including cloud computing firms, hospitals, clinical healthcare centers, investigator consortia, tissue and data banks, Lantern Pharma is continuously advancing its precision oncology therapeutics platform. By AI-driven identification and precision trial-driven validation of complex genetic signatures predictive of patient response, Lantern aims to greatly enhance the value of each drug candidate, thereby creating mutiple exit points for each drug.
RADR or Response Algorithm for Drug Rescue & Positioning is Lantern’s proprietary integrated data analytics, experimental biology and machine learning based platform for patient genetic profiling for robust drug response prediction.
Meet Our Team
Strong scientific and business team with expertise in pharmaceutical development.